Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Neurological Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global neurological biomarkers market grew at a CAGR of around 15% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Neurological biomarkers are molecules present in the blood or cerebral spinal fluid (CSF) that support the diagnosis of brain disorders and monitor disease progression. The main sources of these biomarkers are genetic mutations, metabolite levels, brain imaging and changes in protein expression or post-translational modifications. As they detect biological responses to experimental drugs and aid in discovering new targets for therapeutic intervention, neurological biomarkers are widely used in clinical practice during drug development. Presently, researchers measure biomarker concentrations to provide non-invasive testing, earlier diagnosis and personalized treatments.

The rising occurrence of neurological disorders, such as stroke, motor neuron disease (MND), Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD), is escalating the need for faster drug development. This represents one of the primary factors impelling the market growth as biomarkers help measure the efficacy of new drugs and therapeutic strategies. The increasing adoption of minimally invasive procedures and personalized medicines are acting as another major growth-inducing factor. Apart from this, as various neurological disorders share standard features, there is an increase in the demand for multiple biomarkers to differentiate specific diseases and their sub-types. Moreover, advancements in mass spectrometry and imaging procedures enable faster evaluation of large numbers of biochemical markers and structural changes in the brain. This, along with the introduction of digital biomarkers and the rising number of clinical trials, is anticipated to propel the growth of the market in the coming years. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurological biomarkers market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type, application and end use.

Breakup by Type:

  • Genomic Biomarkers
  • Proteomic Biomarkers
  • Metabolomic Biomarkers
  • Imaging Biomarkers
  • Others
     

Breakup by Application:

  • Alzheimer's Disease
  • Parkinson's Disease
  • Multiple Sclerosis
  • Autism Spectrum Disorders
  • Others
     

Breakup by End Use:

  • Hospital Laboratories
  • Clinical Diagnostic Centers
  • Research Organizations
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Acumen Pharmaceuticals Inc., Athena Diagnostics (Quest Diagnostics), Banyan Biomarkers Inc., Bio-Rad Laboratories Inc., Immunarray Pvt. Ltd., Myriad Rbm, Inc. (Myriad Genetics Inc.), Proteome Sciences Plc and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global neurological biomarkers market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neurological biomarkers market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neurological biomarkers market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology
    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1   Overview
    4.2   Key Industry Trends
5   Global Neurological Biomarkers Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6    Market Breakup by Type
     6.1   Genomic Biomarkers
        6.1.1 Market Trends
        6.1.2 Market Forecast
     6.2   Proteomic Biomarkers
        6.2.1 Market Trends
        6.2.2 Market Forecast
     6.3   Metabolomic Biomarkers
        6.3.1 Market Trends
        6.3.2 Market Forecast
     6.4   Imaging Biomarkers
        6.4.1 Market Trends
        6.4.2 Market Forecast
     6.5   Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Application
     7.1   Alzheimer's Disease
        7.1.1 Market Trends
        7.1.2 Market Forecast
     7.2   Parkinson's Disease
        7.2.1 Market Trends
        7.2.2 Market Forecast
     7.3   Multiple Sclerosis
        7.3.1 Market Trends
        7.3.2 Market Forecast
     7.4   Autism Spectrum Disorders
        7.4.1 Market Trends
        7.4.2 Market Forecast
     7.5   Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by End Use
     8.1   Hospital Laboratories
        8.1.1 Market Trends
        8.1.2 Market Forecast
     8.2   Clinical Diagnostic Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
     8.3   Research Organizations
        8.3.1 Market Trends
        8.3.2 Market Forecast
     8.4   Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
     9.1   North America
          9.1.1   United States
               9.1.1.1 Market Trends
               9.1.1.2 Market Forecast
          9.1.2   Canada
               9.1.2.1 Market Trends
               9.1.2.2 Market Forecast
     9.2   Asia-Pacific
          9.2.1   China
               9.2.1.1 Market Trends
               9.2.1.2 Market Forecast
          9.2.2   Japan
               9.2.2.1 Market Trends
               9.2.2.2 Market Forecast
          9.2.3   India
               9.2.3.1 Market Trends
               9.2.3.2 Market Forecast
          9.2.4   South Korea
               9.2.4.1 Market Trends
               9.2.4.2 Market Forecast
          9.2.5   Australia
               9.2.5.1 Market Trends
               9.2.5.2 Market Forecast
          9.2.6   Indonesia
               9.2.6.1 Market Trends
               9.2.6.2 Market Forecast
          9.2.7   Others
               9.2.7.1 Market Trends
               9.2.7.2 Market Forecast
     9.3   Europe
          9.3.1   Germany
               9.3.1.1 Market Trends
               9.3.1.2 Market Forecast
          9.3.2   France
               9.3.2.1 Market Trends
               9.3.2.2 Market Forecast
          9.3.3   United Kingdom
               9.3.3.1 Market Trends
               9.3.3.2 Market Forecast
          9.3.4   Italy
               9.3.4.1 Market Trends
               9.3.4.2 Market Forecast
          9.3.5   Spain
               9.3.5.1 Market Trends
               9.3.5.2 Market Forecast
          9.3.6   Russia
               9.3.6.1 Market Trends
               9.3.6.2 Market Forecast
          9.3.7   Others
               9.3.7.1 Market Trends
               9.3.7.2 Market Forecast
     9.4   Latin America
          9.4.1   Brazil
               9.4.1.1 Market Trends
               9.4.1.2 Market Forecast
          9.4.2   Mexico
               9.4.2.1 Market Trends
               9.4.2.2 Market Forecast
          9.4.3   Others
               9.4.3.1 Market Trends
               9.4.3.2 Market Forecast
     9.5   Middle East and Africa
          9.5.1 Market Trends
          9.5.2 Market Breakup by Country
          9.5.3 Market Forecast
10    SWOT Analysis
    10.1   Overview
    10.2   Strengths
    10.3   Weaknesses
    10.4   Opportunities
    10.5   Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis
    12.1   Overview
    12.2   Bargaining Power of Buyers
    12.3   Bargaining Power of Suppliers
    12.4   Degree of Competition
    12.5   Threat of New Entrants
    12.6   Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1   Market Structure
    14.2   Key Players
    14.3   Profiles of Key Players
         14.3.1   Abbott Laboratories
              14.3.1.1   Company Overview
              14.3.1.2   Product Portfolio
              14.3.1.3   Financials
              14.3.1.4   SWOT Analysis
         14.3.2   Acumen Pharmaceuticals Inc.
              14.3.2.1   Company Overview
              14.3.2.2   Product Portfolio
         14.3.3   Athena Diagnostics (Quest Diagnostics)
              14.3.3.1   Company Overview
              14.3.3.2   Product Portfolio
         14.3.4   Banyan Biomarkers Inc.
              14.3.4.1   Company Overview
              14.3.4.2   Product Portfolio
         14.3.5   Bio-Rad Laboratories Inc.
              14.3.5.1   Company Overview
              14.3.5.2   Product Portfolio
              14.3.5.3   Financials
              14.3.5.4   SWOT Analysis
         14.3.6   Immunarray Pvt. Ltd.
              14.3.6.1   Company Overview
              14.3.6.2   Product Portfolio
         14.3.7   Myriad Rbm Inc. (Myriad Genetics Inc.)
              14.3.7.1   Company Overview
              14.3.7.2   Product Portfolio
         14.3.8   Proteome Sciences Plc
              14.3.8.1   Company Overview
              14.3.8.2   Product Portfolio
              14.3.8.3   Financials
              14.3.8.4   SWOT Analysis
         14.3.9   Thermo Fisher Scientific Inc.
              14.3.9.1   Company Overview
              14.3.9.2   Product Portfolio
              14.3.9.3   Financials
              14.3.9.4   SWOT Analysis

List of Figures

Figure 1: Global: Neurological Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Neurological Biomarkers Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Neurological Biomarkers Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Neurological Biomarkers Market: Breakup by Type (in %), 2020
Figure 5: Global: Neurological Biomarkers Market: Breakup by Application (in %), 2020
Figure 6: Global: Neurological Biomarkers Market: Breakup by End Use (in %), 2020
Figure 7: Global: Neurological Biomarkers Market: Breakup by Region (in %), 2020
Figure 8: Global: Neurological Biomarkers (Genomic Biomarkers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Neurological Biomarkers (Genomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Neurological Biomarkers (Proteomic Biomarkers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Neurological Biomarkers (Proteomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Neurological Biomarkers (Imaging Biomarkers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Neurological Biomarkers (Imaging Biomarkers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Neurological Biomarkers (Alzheimer's Disease) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Neurological Biomarkers (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Neurological Biomarkers (Parkinson's Disease) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Neurological Biomarkers (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Neurological Biomarkers (Multiple Sclerosis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Neurological Biomarkers (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Neurological Biomarkers (Hospital Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Neurological Biomarkers (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Neurological Biomarkers (Research Organizations) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Neurological Biomarkers (Research Organizations) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: North America: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: North America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: North America: Neurological Biomarkers Market: Breakup by Country (in %), 2020
Figure 39: United States: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: United States: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Canada: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Canada: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Asia-Pacific: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Asia-Pacific: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Asia-Pacific: Neurological Biomarkers Market: Breakup by Country (in %), 2020
Figure 46: China: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: China: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Japan: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Japan: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: India: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: India: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: South Korea: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: South Korea: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Australia: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Australia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Indonesia: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Indonesia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Europe: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Europe: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Europe: Neurological Biomarkers Market: Breakup by Country (in %), 2020
Figure 63: Germany: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Germany: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: France: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: France: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: United Kingdom: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: United Kingdom: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Italy: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Italy: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Spain: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Spain: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Russia: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Russia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Latin America: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Latin America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Latin America: Neurological Biomarkers Market: Breakup by Country (in %), 2020
Figure 80: Brazil: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Brazil: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Mexico: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Mexico: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 86: Middle East and Africa: Neurological Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 87: Middle East and Africa: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Middle East and Africa: Neurological Biomarkers Market: Breakup by Country (in %), 2020
Figure 89: Global: Neurological Biomarkers Industry: SWOT Analysis
Figure 90: Global: Neurological Biomarkers Industry: Value Chain Analysis
Figure 91: Global: Neurological Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurological Biomarkers Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Neurological Biomarkers Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Neurological Biomarkers Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Neurological Biomarkers Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 5: Global: Neurological Biomarkers Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Neurological Biomarkers Market: Competitive Structure
Table 7: Global: Neurological Biomarkers Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links